Cefazolin in Dextrose Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Cefazolin in Dextrose Injection (injection) from Baxter Healthcare with status To Be Discontinued. The shortage was first posted on Oct 30, 2026.
Shortage details
- Status
- To Be Discontinued
- Company
- Baxter Healthcare
- Package NDC
- 0338-3508-41
- Dosage Form
- Injection
- Presentation
- Cefazolin in Dextrose, Injection, 2g/100mL (NDC 0338-3508-41)
- Initial Posting
- Oct 30, 2026